Notice: This company has been marked as potentially delisted and may not be actively trading. Spectrum Pharmaceuticals (SPPI) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Non-Hodgkin’s Lymphoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersNovember 4, 2024 | theglobeandmail.comQylur Awarded SBIR Phase II Contract for a Tactical AI Spectrum Classifier Systems (TASCS)October 2, 2024 | globenewswire.comNanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387August 19, 2024 | proactiveinvestors.comSTALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in BiomedicinesJune 27, 2024 | globenewswire.comOsivax Completes Enrollment for Phase 1 Trial with Broad-Spectrum Sarbecovirus Vaccine Candidate, OVX033June 25, 2024 | businesswire.comPneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 ConferenceMay 23, 2024 | globenewswire.comPneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024May 2, 2024 | globenewswire.comAssertio Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - ASRTFebruary 21, 2024 | markets.businessinsider.comLevi & Korsinsky Notifies Shareholders of Assertio Holdings, Inc.(ASRT) of a Class Action Lawsuit and an Upcoming DeadlineFebruary 21, 2024 | markets.businessinsider.comLost Money on Assertio Holdings, Inc.(ASRT)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyFebruary 8, 2024 | markets.businessinsider.comAssertio Holdings, Inc. (NASDAQ: ASRT) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class ActionFebruary 5, 2024 | markets.businessinsider.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Assertio Holdings, Inc. (ASRT)February 1, 2024 | stockhouse.comCLASS ACTION NOTICE: Berger Montague Encourages Assertio Holdings, Inc. (ASRT) Investors to Inquire About a Securities Fraud Class ActionFebruary 1, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Levi & Korsinsky Notifies Assertio Holdings, Inc.(ASRT) Investors of a Class Action Lawsuit and Upcoming DeadlineJanuary 30, 2024 | stockhouse.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Assertio Holdings, Inc. (ASRT) InvestorsJanuary 26, 2024 | tmcnet.comINVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Assertio Holdings, Inc.(ASRT) of a Class Action Lawsuit and an Upcoming DeadlineJanuary 13, 2024 | stockhouse.comEye Melanoma Market Size Worth USD 9.56 Billion in 2032 | Emergen ResearchJanuary 12, 2024 | finance.yahoo.comVaccine Adjuvant Market Size Worth USD 1.75 Billion in 2032 | Emergen ResearchJanuary 10, 2024 | finance.yahoo.comSHAREHOLDER ALERT: Potential Recovery for Assertio Holdings, Inc. (ASRT) InvestorsJanuary 9, 2024 | msn.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Assertio Holdings, Inc. - ASRTNovember 9, 2023 | markets.businessinsider.comTrading was temporarily halted for "SPPI" at 07:07 PM with a stated reason of "News pending."August 1, 2023 | marketbeat.comBuy Spectrum Pharmaceuticals For Exposure To Assertio HoldingsJuly 24, 2023 | seekingalpha.comSpectrum Pharmaceuticals (NASDAQ:SPPI) Research Coverage Started at StockNews.comStockNews.com assumed coverage on shares of Spectrum Pharmaceuticals in a research report on Monday. They issued a "hold" rating for the company.July 24, 2023 | marketbeat.comSpectrum Pharmaceuticals (NASDAQ: SPPI)July 8, 2023 | fool.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Receives Average Recommendation of "Hold" from AnalystsShares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI - Free Report) have received an average rating of "Hold" from the five brokerages that are covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold rating. The average 1-year price objective among brokerages thaJuly 4, 2023 | marketbeat.comMoore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law FirmJuly 3, 2023 | benzinga.comSPPI - Spectrum Pharmaceuticals, Inc.June 30, 2023 | finance.yahoo.comAre (More) Big Gains Ahead for This Small Cap Biotech Stock? (SPPI)With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.June 28, 2023 | marketbeat.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Given Average Rating of "Hold" by AnalystsSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI - Get Rating) has earned an average rating of "Hold" from the six analysts that are currently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating. The average twelve-month price target among analysts tJune 9, 2023 | marketbeat.comHC Wainwright Comments on Spectrum Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:SPPI)Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI - Get Rating) - HC Wainwright issued their Q3 2023 earnings per share estimates for Spectrum Pharmaceuticals in a research note issued on Friday, May 26th. HC Wainwright analyst E. White expects that the biotechnology company will earn $0.01 per share fMay 29, 2023 | marketbeat.comHC Wainwright & Co. Reiterates Spectrum Pharmaceuticals (SPPI) Neutral RecommendationMay 26, 2023 | msn.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Short Interest Down 49.2% in MaySpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI - Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 3,080,000 shares, a decrease of 49.2% from the April 30th total of 6,060,000 shares. Based on an average daily volume of 2,290,000 shares, the short-interest ratio is presently 1.3 days.May 26, 2023 | marketbeat.comSpectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementMay 17, 2023 | finance.yahoo.comJefferies Downgrades Spectrum Pharmaceuticals (SPPI)May 15, 2023 | msn.comNews Flash: Analysts Just Made A Captivating Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) ForecastsMay 14, 2023 | finance.yahoo.comQ1 2023 Assertio Holdings Inc Earnings CallMay 10, 2023 | finance.yahoo.comSpectrum Pharmaceuticals rises as co. says its Q1 net sales up 54% Q/QMay 9, 2023 | msn.comSpectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue EstimatesMay 9, 2023 | finance.yahoo.comB.Riley Financial Remains a Hold on Spectrum Pharmaceuticals (SPPI)May 5, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Weiss Law Reminds SPPI, NATI, CCFN, and ARST Shareholders About Its Ongoing InvestigationsMay 1, 2023 | benzinga.comLifshitz Law PLLC Announces Investigations of HOTH, ASRT, SPPI, and CEIApril 30, 2023 | benzinga.comMoore Kuehn Encourages HOTH, HSKA, SPPI, and GLOP Investors to Contact Law FirmApril 28, 2023 | benzinga.comSHAREHOLDER ALERT: Weiss Law Investigates Spectrum Pharmaceuticals, Inc.April 27, 2023 | benzinga.comSpectrum Pharmaceuticals Stock (NASDAQ:SPPI), Short Interest ReportApril 27, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Spectrum Pharmaceuticals, Inc. BuyoutApril 26, 2023 | benzinga.comExpert Ratings for Spectrum PharmaApril 26, 2023 | markets.businessinsider.comHC Wainwright & Co. Downgrades Spectrum Pharmaceuticals (SPPI)April 26, 2023 | msn.comJMP Securities Downgrades Spectrum Pharmaceuticals (SPPI)April 26, 2023 | msn.comJMP Securities downgrades Spectrum Pharmaceuticals (SPPI) to a HoldApril 26, 2023 | markets.businessinsider.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Spectrum Pharmaceuticals, Inc.April 26, 2023 | benzinga.com Get Spectrum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SPPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad)If you missed out on Nvidia, watch this video I just made. Click here for full details. SPPI Media Mentions By Week SPPI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPPI News Sentiment▼0.000.50▲Average Medical News Sentiment SPPI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPPI Articles This Week▼00▲SPPI Articles Average Week Get Spectrum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SPPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EGRX News IRWD News EBS News RIGL News SGMO News XOMA News CDXS News VNDA News LXRX News VSTM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPPI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectrum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectrum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPPI Stock Alerts